S.Amdt. 1019Senate110th Congress (2007-2009)

To express the sense of the Senate concerning orphan disease treatment in children.

What it does: Adds SEC. __. ORPHAN DISEASE TREATMENT IN CHILDREN wherever appropriate
Submitted May 2, 2007

What it changes

1 change to S. 1082

Adds a section
  1. Adds SEC. __. ORPHAN DISEASE TREATMENT IN CHILDREN wherever appropriate

    Adds a section

    Inserted: SEC. __. ORPHAN DISEASE TREATMENT IN CHILDREN.

    Inserted: (a) Finding.--The Senate finds that parents of children suffering from rare genetic diseases known as orphan diseases face multiple obstacles in obtaining safe and effective treatment for their children due mainly to the fact that many Food and Drug Administration-approved drugs used in the treatment of orphan diseases in children may not be approved for pediatric indications.

    Inserted: (b) Sense of the Senate.--It is the sense of the Senate that the Food and Drug Administration should enter into a contract with the Institute of Medicine for the conduct of a study concerning measures that may be taken to improve the likelihood that Food and Drug Administration-approved drugs that are safe and effective in treating children with orphan diseases are made available and affordable for pediatric indications.

    The amendment doesn't say where this goes; the clerk decides.

    Original wording

    At the appropriate place, insert the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed

At the appropriate place, insert the following:

SEC. __. ORPHAN DISEASE TREATMENT IN CHILDREN.

(a) Finding.--The Senate finds that parents of children suffering from rare genetic diseases known as orphan diseases face multiple obstacles in obtaining safe and effective treatment for their children due mainly to the fact that many Food and Drug Administration-approved drugs used in the treatment of orphan diseases in children may not be approved for pediatric indications.

(b) Sense of the Senate.--It is the sense of the Senate that the Food and Drug Administration should enter into a contract with the Institute of Medicine for the conduct of a study concerning measures that may be taken to improve the likelihood that Food and Drug Administration-approved drugs that are safe and effective in treating children with orphan diseases are made available and affordable for pediatric indications.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

4 earlier actions
Floor Latest Action

Senate amendment agreed to: Amendment SA 1019 agreed to in Senate by Unanimous Consent.

May 8, 2007

View full timeline
Floor

Senate amendment agreed to: Amendment SA 1019 agreed to in Senate by Unanimous Consent.

May 8, 2007

Floor

Senate amendment proposed (on the floor): Amendment SA 1019 proposed by Senator Brown for Senator Casey.(consideration: CR S5699-5705; text: CR S5702)

May 8, 2007

Floor

Amendment SA 1019 proposed by Senator Brown for Senator Casey. (consideration: CR S5699-5705; text: CR S5702) To express the sense of the Senate concerning orphan disease treatment in children.

May 8, 2007

Floor

Amendment SA 1019 agreed to in Senate by Unanimous Consent.

May 8, 2007

Floor

Senate amendment submitted

May 2, 2007